Does Splenectomy Enhance Results of Distal Pancreatectomy for Body Pancreatic Ductal Adenocarcinoma?

After assessing spleen-preserving distal pancreatectomy (SPDP) and distal splenopancreatectomy (DSP) for body pancreatic ductal adenocarcinoma, it was found that SPDP is associated with less postoperative morbidity and does not impair oncological outcomes. Propensity score matching balanced patient characteristics, showing that SPDP is a viable option for b-PDAC patients located at least 5 cm from the spleen hilum, potentially eliminating the need for splenectomy in these cases.